OSCR NYSE Week ended 09 Oct 2026

Weekly Investor Report

Oscar Health Inc · Healthcare · Healthcare Plans

Open interactive chart View report data
Latest close 33.37 USD
7.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 30.5% above the Trend Line and sits at 95.3% of its 52-week range. The latest completed week returned 7.9%, after a 1.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. Options positioning is volatility with 61/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high; earnings are due in 23d.

Setup score 58 out of 100
Latest Close 33.37 USD 9 Oct 2026
1W Return 7.9% latest completed week
4W Return 1.8% short-term follow-through
12W Return 14.7% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 21-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 10 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.9% Latest completed week; four-week move 1.8%. Indicator stack 72/12 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 61/100 conviction; expected move 8.0%. News sentiment 55/100 59 relevant articles in the latest sentiment read. Event risk 23d Next report is scheduled for 05 Nov 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 30.5% above the Trend Line and sits at 95.3% of its 52-week range. The latest completed week returned 7.9%, after a 1.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug 21 Aug 28 Aug 4 Sep 11 Sep 18 Sep 25 Sep 2 Oct 9 Oct
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9512-week average 0.96

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.95Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1010 reversal markers

No recent accumulation markers. 10 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.8% over four weeks, 14.7% over 12 weeks, and 77.8% over one year. The current trend has remained active for 21 consecutive weeks.

Performance by holding period

1W7.9%
4W1.8%
12W14.7%
26W130.9%
52W77.8%
Active trend streak21 weeks
Active weeks in one year26
Trend breadth50.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.32Latest activity-pressure read.
Pressure change-404.3%Four-week change in activity pressure.
Leadership45.10Latest relative-leadership reading.
RS change-9.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Oct 2026 Financial statements through 30 Jun 2026 Field coverage 91% Model confidence 89%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength95/100Blend of value, momentum, and quality. Underlying universe rank 6; rank 1 is best.
Value85/100Relative valuation strength. Underlying universe rank 16; rank 1 is best.
Quality76/100Profitability and accounting quality. Underlying universe rank 25; rank 1 is best.
Momentum93/100Medium-term price momentum. Underlying universe rank 8; rank 1 is best.
Growth85/100Revenue and earnings growth. Underlying universe rank 16; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.7x
Price divided by trailing earnings.
Price / sales
0.7x
Market value relative to trailing revenue.
EV / EBITDA
10.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
65.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
44.9%
Gross profit retained from each unit of revenue.
Operating margin
4.1%
Operating profit retained from revenue.
Free-cash-flow margin
28.3%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
42.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
260.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.5%
Net share repurchases relative to market value.
Shareholder yield
-0.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-5.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

OSCR shows volatility options pressure with a 61/100 conviction score, put-call volume ratio of 0.27, expected move of 8.0%, and Sharemaestro trend signal active.

Conviction61/100
Expected move8.0%
Put/call volume0.27
Pressure63
Speculation41
Volatility81
Trend agreement68
Open options detail
Insider activity8 / 12

8 acquisitions and 12 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 59 relevant articles.

12 positive · 42 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings23dNext report is scheduled for 05 Nov 2026; event risk rises as the date approaches.
Options expected move8.0%Nearest-chain priced movement where available.
52-week drawdown-3.2%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 2610 weeks finished lower.
Best week+17.4%Week of 14 Aug.
Worst week-10.6%Week of 7 Aug.
Latest week+7.9%Week of 9 Oct.

Shape of recent returns

Strong gains14
Modest gains2
Flat weeks0
Modest losses5
Sharp losses5
Recent vol7.7%13-week weekly-return volatility.
Base vol9.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew9.1% / -5.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape58/100

Trend, activity pressure, participation, and risk combine to a 58/100 tape read.

 Indicator analysis74/100

Latest 12-week confirmation: trend 12/12, activity pressure 7/12, relative leadership 12/12.

Activity pressure 0.95; 10 reversal markers Factors86/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 83; Small Cap Core rank 39 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options57/100

Movement matters more than direction. Options do not give a clear directional confirmation of the stock trend.

2026-10-12 · Checks passed · Priced move ±8.0% Sentiment55/100

Weighted news tone is neutral across 59 relevant articles.

Oscar Health, Inc. (OSCR) Stock Price, News, Quote & History Insiders8 / 12

8 acquisitions and 12 disposals in the latest 180-day insider tape.

 Earnings23d

Next report is scheduled for 05 Nov 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
9 Oct 202633.37 USD7.9%25.57 USD17.28 USD-0.3245.1024.5MOn
2 Oct 202630.94 USD4.5%24.90 USD17.09 USD-0.3037.3321.1MOn
25 Sep 202629.60 USD-7.9%24.33 USD16.93 USD-0.1731.7532.9MOn
18 Sep 202632.13 USD-2.0%23.80 USD16.78 USD-0.1345.8230.8MOn
11 Sep 202632.77 USD1.6%23.17 USD16.61 USD-0.0649.9121.2MOn
4 Sep 202632.25 USD5.8%22.52 USD16.44 USD0.1447.7221.7MOn
28 Aug 202630.47 USD-4.9%21.86 USD16.27 USD0.2840.8321.8MOn
21 Aug 202632.04 USD-2.2%21.32 USD16.12 USD0.5450.1826.3MOn
14 Aug 202632.76 USD17.4%20.77 USD15.95 USD0.6153.1030.7MOn
7 Aug 202627.90 USD-10.6%20.23 USD15.79 USD0.6832.2139.6MOn
31 Jul 202631.22 USD10.7%19.89 USD15.66 USD0.8854.4023.9MOn
24 Jul 202628.19 USD-3.1%19.35 USD15.50 USD0.9942.9418.7MOn
17 Jul 202629.10 USD-4.7%18.91 USD15.37 USD1.2248.3220.9MOn
10 Jul 202630.54 USD-5.1%18.44 USD15.23 USD1.2855.2323.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context